Functional Comparison of Blood-Stage Plasmodium falciparum Malaria Vaccine Candidate Antigens
Clicks: 204
ID: 268483
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
The malaria genome encodes over 5,000 proteins and many of these have also been proposed to be potential vaccine candidates, although few of these have been tested clinically. RH5 is one of the leading blood-stage Plasmodium falciparum malaria vaccine antigens and Phase I/II clinical trials of vaccines containing this antigen are currently underway. Its likely mechanism of action is to elicit antibodies that can neutralize merozoites by blocking their invasion of red blood cells (RBC). However, many other antigens could also elicit neutralizing antibodies against the merozoite, and most of these have never been compared directly to RH5. The objective of this study was to compare a range of blood-stage antigens to RH5, to identify any antigens that outperform or synergize with anti-RH5 antibodies. We selected 55 gene products, covering 15 candidate antigens that have been described in the literature and 40 genes selected on the basis of bioinformatics functional prediction. We were able to make 20 protein-in-adjuvant vaccines from the original selection. Of these, S-antigen and CyRPA robustly elicited antibodies with neutralizing properties. Anti-CyRPA IgG generally showed additive GIA with anti-RH5 IgG, although high levels of anti-CyRPA-specific rabbit polyclonal IgG were required to achieve 50% GIA. Our data suggest that further vaccine antigen screening efforts are required to identify a second merozoite target with similar antibody-susceptibility to RH5.| Reference Key |
draper2019frontiersfunctional
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Joseph J. Illingworth,Daniel G. Alanine,Rebecca Brown,Jennifer M. Marshall,Helen E. Bartlett,Sarah E. Silk,Geneviève M. Labbé,Doris Quinkert,Jee Sun Cho,Jason P. Wendler,David J. Pattinson,Lea Barfod,Alexander Douglas,Michael W. Shea,Katherine E. Wright,Simone C. De Cassan,Matthew K. Higgins,Simon J. Draper;Joseph J. Illingworth;Daniel G. Alanine;Rebecca Brown;Jennifer M. Marshall;Helen E. Bartlett;Sarah E. Silk;Geneviève M. Labbé;Doris Quinkert;Jee Sun Cho;Jason P. Wendler;David J. Pattinson;Lea Barfod;Alexander Douglas;Michael W. Shea;Katherine E. Wright;Simone C. De Cassan;Matthew K. Higgins;Simon J. Draper; |
| Journal | Frontiers in immunology |
| Year | 2019 |
| DOI | 10.3389/fimmu.2019.01254 |
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.